EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Glutathione‐Related Metabolite Levels and Enzyme Activities in Depression: A Systematic Review and Meta‐Analysis

Takahide Etani iD, Nobuaki Hondo iD, Sho Moriguchi iD, Kazunari Yoshida iD, Sotaro Moriyama iD, Koki Takahashi iD, Tahichi Moritake, Yumina Nakamura, Ryoma Kani iD, Shiori Honda, Masataka Wada iD, Sakiko Tsugawa iD und 5 weitere

Neuropsychopharmacology Reports · 2026-06 · 46 (2)

DOI: 10.1002/npr2.70125 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 30.04.2026. Verfasst von Takahide Etani und 16 weiteren Autor:innen. Beteiligte Einrichtung: Keio University Hospital, Shinjuku-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Glutathione, Depression. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Japan Research Foundation for Clinical Pharmacology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, an increasing number of studies have reported abnormal levels of glutathione (GSH)‐related metabolites and enzyme activities in neuroimaging and peripheral samples in patients with depression, indicating abnormalities in the GSH cycle in patients with depression. However, the abnormalities in the GSH cycle have not been comprehensively investigated. Here, we conducted a systematic review and meta‐analysis to compare the levels of GSH‐related metabolites (GSH and GSH disulfide [GSSG]) and the activities of GSH‐related enzymes (Glutathione‐peroxidase [GPx], GSH reductase [GR], glutamate‐cysteine ligase [GCL], GSH synthetase [GS], and GSH S‐transferase [GST]) between patients with depression and healthy controls (HC). The search was performed with MEDLINE, Embase, and PsychINFO. The inclusion criteria were studies comparing levels of GSH‐related metabolites and enzyme activities between patients with depression and HC. Standardized mean differences were calculated to assess group differences. Thirty studies met the eligibility criteria, which included 1019 patients and 947 HC. Our meta‐analysis indicated significantly decreased activity of GPx in patients with depression compared with HC, while the levels of GSH and GR were not significantly different between the groups. Because no studies, or an insufficient number of studies, have been conducted on GSSG, GST, GCL, and GS, meta‐analyses were not performed for these metabolites and enzyme activities. Our findings suggest that abnormal cycling of the GSH system, particularly decreased GPx activity, is involved in the pathophysiology of depression and may serve as a potential biomarker for this illness. Furthermore, given that no or insufficient studies have been conducted on GSSG, GST, GCL, and GS, this study highlights the need for further research to fully elucidate the GSH cycle in patients with depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlutathioneDepressionHumansGlutathione TransferaseGlutamate-Cysteine LigaseGlutathione ReductaseGlutathione PeroxidaseGlutathione Synthase

Stichwörter der Autor:innen

depressionglutathioneoxidative stresssystematic review and meta‐analysis

Substanzen

GlutathioneGlutathione TransferaseGlutamate-Cysteine LigaseGlutathione ReductaseGlutathione PeroxidaseGlutathione Synthase

Autor:innen und Institutionen

  • Keio University Hospital, Shinjuku-ku, Tokyo, Japan.
  • Japanese Red Cross Ashikaga Hospital, Ashikaga-shi, Tochigi, Japan.
  • Graduate School of Media and Governance, Keio University, Fujisawa-shi, Kanagawa, Japan.
  • Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • National Institutes for Quantum Science and Technology, Chiba-shi, Chiba, Japan.
  • Postgraduate Education Center Kameda Medical Center, Kamogawa-shi, Chiba, Japan.

ORCID-Profile: Takahide Etani, Nobuaki Hondo, Sho Moriguchi, Kazunari Yoshida, Sotaro Moriyama, Koki Takahashi, Ryoma Kani, Masataka Wada, Sakiko Tsugawa, Tony Kaku, Hiroyuki Uchida, Shinichiro Nakajima

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Japan Research Foundation for Clinical Pharmacology
  • Naito Foundation
  • Watanabe Foundation
  • Takeda Science Foundation

Zitieren

APA

Etani, T., Hondo, N., Moriguchi, S., Yoshida, K., Moriyama, S., Takahashi, K., Moritake, T., Nakamura, Y., Kani, R., Honda, S., Wada, M., Tsugawa, S., Mori, Y., Segawa, H., Kaku, T., Uchida, H., & Nakajima, S. (2026). Glutathione‐Related Metabolite Levels and Enzyme Activities in Depression: A Systematic Review and Meta‐Analysis. Neuropsychopharmacology Reports, 46(2). https://doi.org/10.1002/npr2.70125

Vancouver

Etani T, Hondo N, Moriguchi S, Yoshida K, Moriyama S, Takahashi K, et al. Glutathione‐Related Metabolite Levels and Enzyme Activities in Depression: A Systematic Review and Meta‐Analysis. Neuropsychopharmacology Reports. 2026;46(2). doi:10.1002/npr2.70125

BibTeX
@article{Etani2026,
  author = {Etani, Takahide and Hondo, Nobuaki and Moriguchi, Sho and Yoshida, Kazunari and Moriyama, Sotaro and Takahashi, Koki and Moritake, Tahichi and Nakamura, Yumina and Kani, Ryoma and Honda, Shiori and Wada, Masataka and Tsugawa, Sakiko and Mori, Yukino and Segawa, Hikari and Kaku, Tony and Uchida, Hiroyuki and Nakajima, Shinichiro},
  title = {Glutathione‐Related Metabolite Levels and Enzyme Activities in Depression: A Systematic Review and Meta‐Analysis},
  journal = {Neuropsychopharmacology Reports},
  year = {2026},
  volume = {46},
  number = {2},
  doi = {10.1002/npr2.70125}
}
Kostenlos starten →